Coldstream Capital Management Inc Laboratory Corp Of America Holdings Transaction History

Coldstream Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$209.01 - $232.56 $160,728 - $178,838	-769 Reduced 28.22%	1,956 $427,000
Q4 2023 Feb 09, 2024	BUY	$197.69 - $227.29 $267,474 - $307,523	1,353 Added 98.62%	2,725 $619,000
Q3 2023 Nov 02, 2023	SELL	$201.05 - $221.7 $1,407 - $1,551	-7 Reduced 0.51%	1,372 $275,000
Q2 2023 Aug 03, 2023	SELL	$211.93 - $241.33 $4,026 - $4,585	-19 Reduced 1.36%	1,379 $332,000
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $24,531 - $29,650	115 Added 8.96%	1,398 $320,000
Q4 2022 Jan 10, 2023	BUY	$203.72 - $248.97 $17,112 - $20,913	84 Added 7.01%	1,283 $0
Q2 2022 Aug 08, 2022	BUY	$213.86 - $277.87 $256,418 - $333,166	1,199 New	1,199 $281,000
Q2 2022 Aug 08, 2022	SELL	$213.86 - $277.87 $214,715 - $278,981	-1,004 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$259.82 - $298.18 $32,477 - $37,272	-125 Reduced 11.07%	1,004 $265,000
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $306,636 - $354,743	1,129 New	1,129 $355,000
Q2 2021 Aug 16, 2021	SELL	$251.87 - $278.14 $203,259 - $224,458	-807 Closed	0 $0
Q1 2021 Jun 16, 2021	BUY	$204.88 - $255.03 $165,338 - $205,809	807 New	807 $206,000

128

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Coldstream Capital Management Inc with notifications on news.